In a first, FDA authorizes flavored vape products from Altria’s NJOY for sale

HEALTH-ECIGARETTES/ALTRIA GROUP (UPDATE 1, PIX):UPDATE 1-In a first, FDA authorizes flavored vape products from Altria's NJOY for s

Reuters
Published22 Jun 2024, 12:11 AM IST
In a first, FDA authorizes flavored vape products from Altria's NJOY for sale
In a first, FDA authorizes flavored vape products from Altria’s NJOY for sale

(Adds background in paragraphs 2 to 6, comments in paragraphs 9, 11)

By Emma Rumney and Juveria Tabassum

June 21 (Reuters) - The U.S. Food and Drug Administration authorized four of Altria's menthol e-cigarette products for sale in the country on Friday, making them the first ever flavored vapes the agency has permitted on the market.

The decision shows vape makers can provide evidence satisfying the FDA that the benefits their products offer in terms of helping smokers quit outweigh the risks posed to youth.

"In this instance, the strength of evidence of benefits to adult smokers from completely switching to a less harmful product was sufficient to outweigh the risks to youth," said Matthew Farrelly, director of the Office of Science at the FDA's Center for Tobacco Products.

The FDA first began regulating e-cigarettes in August 2016 and it has authorized 27 e-cigarette products for sale in the U.S. to date, including Altria-owned NJOY's menthol vape products.

The regulator has rejected the vast majority of the 26 million applications it has reviewed so far, including from British American Tobacco, and all of those relating to flavored products.

This has sparked pushback from the industry, with manufacturers launching court cases to challenge its decisions, some of which were successful.

The agency's nod to Altria's NJOY menthol vape products was a positive for the broader industry sentiment, and bodes well for flavors ultimately getting back on the market with Bluetooth age-verified technology, Jefferies analyst Owen Bennett said in a note.

The U.S. is the world's largest market for e-cigarettes, and the FDA has had to crack down on the sale and distribution of illicit vapes.

"This decision is especially troubling given the FDA's failure to do its job and clear the market of unauthorized, illegal e-cigarette products," said Yolonda Richardson, CEO of Campaign for Tobacco-Free Kids, adding that the decision was "hard to understand".

The FDA's authorization comes at a time when the U.S. government is reviewing a potential ban on menthol cigarettes.

Earlier this month, the FDA rescinded market denial orders issued in 2022 for four varieties of Juul Lab's tobacco and menthol-flavored pods and its e-cigarette device. (Reporting by Juveria Tabassum and Emma Rumney; Editing by Pooja Desai and Vijay Kishore)

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.MoreLess
First Published:22 Jun 2024, 12:11 AM IST
HomeCompaniesNewsIn a first, FDA authorizes flavored vape products from Altria’s NJOY for sale

Most Active Stocks

Tata Steel

157.75
03:43 PM | 19 JUL 2024
-8.6 (-5.17%)

Tata Power

414.15
03:59 PM | 19 JUL 2024
-15.85 (-3.69%)

Bharat Electronics

306.30
03:45 PM | 19 JUL 2024
-7.2 (-2.3%)

Zee Entertainment Enterprises

137.55
03:57 PM | 19 JUL 2024
-4.9 (-3.44%)
More Active Stocks

Market Snapshot

  • Top Gainers
  • Top Losers
  • 52 Week High

Tata Teleservices Maharashtra

102.11
03:59 PM | 19 JUL 2024
4.68 (4.8%)

Rail Vikas Nigam

614.00
03:59 PM | 19 JUL 2024
27.65 (4.72%)

Jubilant Pharmova

752.25
03:43 PM | 19 JUL 2024
25.3 (3.48%)

One 97 Communications

458.70
03:55 PM | 19 JUL 2024
13.65 (3.07%)
More from Top Gainers

Recommended For You

    More Recommendations

    Gold Prices

    • 24K
    • 22K
    Bangalore
    76,272.001,173.00
    Chennai
    76,124.001,465.00
    Delhi
    75,533.001,021.00
    Kolkata
    75,089.00-450.00

    Fuel Price

    • Petrol
    • Diesel
    Bangalore
    102.86/L0.00
    Chennai
    100.76/L0.00
    Kolkata
    104.95/L0.00
    New Delhi
    94.72/L0.00
    OPEN IN APP
    HomeMarketsCibilPremiumBudget